Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.84% | -87.32% | -22.52% | -2.57% | 12.50% |
| Total Depreciation and Amortization | -28.57% | -13.85% | -5.43% | -3.10% | -0.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 456.59% | 847.00% | 1,330.83% | 70.98% | -58.70% |
| Change in Net Operating Assets | 140.26% | -111.59% | 426.89% | 988.89% | -85.76% |
| Cash from Operations | 4.72% | 5.17% | 15.02% | 10.63% | -1.15% |
| Capital Expenditure | -- | 100.00% | 100.00% | 89.52% | 89.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 89.52% | 89.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 485.54% | 129.81% | 357.22% | 214.53% | 11.88% |
| Repurchase of Common Stock | 69.23% | 100.00% | 96.55% | -4.00% | -4.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 488.65% | 130.50% | 360.57% | 215.85% | 11.93% |
| Foreign Exchange rate Adjustments | 259.38% | -785.71% | -64.71% | 23.08% | -52.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.87% | 82.19% | 84.58% | 55.44% | 1.65% |